🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shaveta Vinayak

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

ORCID: 0000-0001-9197-7316

Also affiliated with University of Washington, Fred Hutch Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.271Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618
Top 58%
0.271DataRank
Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Papers

Driven by 9 papers — median percentile 21. Top paper: “Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study”.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618
Top 58%
0.271DataRank
Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death

npj Breast Cancer(2025)10.1038/s41523-025-00790-3
N/A
0.165DataRank · unranked
2 citations

Yuanning Zheng, A. Mantz, Ryle Zhou, Andrew Kozlov, Wendy B. DeMartini +15 more

Computational features of tumor-infiltrating lymphocyte architecture of residual disease after chemotherapy on H&E images as prognostic of overall and disease-free survival for triple-negative breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.584
N/A
0DataRank · unranked
3 citations

Paula Toro, Cheng Lu, Pingfu Fu, Shaveta Vinayak, Miluska Castillo +7 more

Matched FES and FDG PET imaging in patients with hormone receptor-positive, HER2+ advanced breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1042
N/A
0DataRank · unranked
1 citations

Lanell M. Peterson, David A. Mankoff, Mark Muzi, Delphine L. Chen, Shaveta Vinayak +4 more

Exploring homologous recombination deficiency thresholds for predicting response to platinum-based treatment in triple negative breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.525
N/A
0DataRank · unranked
0 citations

Lauren Lenz, Elizabeth S. Cogan, Erica L. Mayer, Virginia Kaklamani, Vered Stearns +15 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038
Top 100%
0DataRank
Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA -Mutant Colorectal Cancers

Cancer Research(2020)10.1158/0008-5472.can-20-0600
N/A
0DataRank · unranked
142 citations

Xiujing Feng, Yicheng Chen, J. Eva Selfridge, Shashank Gorityala, Zhanwen Du +16 more

Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer

Breast Cancer Research(2025)10.1186/s13058-025-01975-1
N/A
0DataRank · unranked
1 citations

Lanell M. Peterson, Jennifer M. Specht, David A. Mankoff, Mark Muzi, Delphine L. Chen +5 more

Selection of Adjuvant Endocrine Therapy for Women With Breast Cancer in Menopausal Transition: Is It Simpler Than We Thought?

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab092
N/A
0DataRank · unranked
1 citations

Nancy E. Davidson, Shaveta Vinayak